Partner William Shreve was quoted in, “PTAB Won’t Rehear Challenge To Nomadix Network Patents,” an article published by Law360. Excerpt: “The Patent Trial and Appeal Board on Wednesday refused to revive claims from…
Partner Lauren Hockett was quoted in, “What the ML Patent Application Boom Means for Tech,” an article published by Datanami. Excerpt: “There has been a surge in applications of machine learning over the…
Knobbe Martens is pleased to announce that it has obtained a dismissal of patent litigation brought by Dominion Assets LLC (“Dominion”) against long-time Knobbe client, Masimo Corporation. This is the…
Knobbe Martens is pleased to announce that fifteen partners, including Maria Anderson, John M. Carson, Joseph S. Cianfrani, Joseph F. Jennings, Steven Nataupsky, Carol Pitzel Cruz, Joseph R. Re, Joseph…
Knobbe Martens had the opportunity recently to advise pro bono client The Trail Youth on key trademark matters prior to its high-profile appearance on national reality series Returning the Favor….
Partner Kerry Taylor was quoted in, “The Top Patent Cases of 2018: Midyear Report,” an article published by Law360. Excerpt: “The Federal Circuit imposed new hurdles to invalidating patents for claiming ineligible subject…
Partner Kerry Taylor was quoted in, “Lessons From This Year’s High Court Patent Rulings,” an article published by Law360. Excerpt: “It was another busy term for patent law at the U.S. Supreme Court, as the…
Congratulations to Partners Jared Bunker and Jonathan Bachand for being named leading litigation attorneys in Benchmark Litigation’s 2018 “Under 40 Hot List”. Benchmark Litigation exclusively recognizes notable up-and-coming litigation attorneys…
Partner Brent Babcock was quoted in, “Patent Awards Give Berkeley a Needed Gene-Edit Boost,” an article published by Bloomberg Law. Excerpt: “The University of California, Berkeley, is on the board in the ongoing…
Partner Brent Babcock was quoted in, “Pharma, Biotech Patent Holders Lament Appeal Board Survival,” an article published by Bloomberg Law. Excerpt: “Pharmaceutical and life sciences patent holders may be unhappy the…
